Try our Advanced Search for more refined results

US Trustee Flags Ch. 11 Sale Restrictions In Bid For Aegerion

By Ryan Boysen (June 20, 2019, 9:33 PM EDT) -- The federal bankruptcy watchdog cried foul on Thursday about Amryt Pharma PLC's $400 million bid for embattled specialty drug company Aegerion, saying overly restrictive rules proposed by the pair could prevent other bids from coming in and "predetermine the outcome" of Aegerion's bankruptcy auction....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!